Due to prospective for severe adverse reactions in infants from mitoxantrone, breastfeeding should be discontinued before beginning therapy. Individuals who experienced an incomplete antileukemic reaction received a next induction training course wherein mitoxantrone or daunorubicin was administered for 2 times and cytarabine for 5 days using the identical every day https://ericksxcfh.yomoblog.com/38707791/getting-my-hg-9-91-01-to-work